From the quarterly the production costs were very low last quarter at $146000, compared with $482000 the previous quarter. I assume they are running down inventory given the low level of sales.
What costs were incurred on production last quarter may relate to Phosflow.
Thus if sales pick up so will costs.
Ann: Strategic Review, page-35
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PET (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.60M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| PET (ASX) Chart |
Day chart unavailable